Production facility
BMC NANOLEK provides for the use of several technologies to ensure full-cycle production of drugs.
- Production of solid dosage forms. Start of production - December 2014.
- Biotechnological production (in syringes and vials). Start of full-cycle production – 4th quarter of 2016.
- Production of cytostatic drugs in solid and injectable dosage forms.
- Laboratories: chemical-analytical, microbiological, biochemical.
Capabilities of manufacturing site
- Construction "from greenfield" (14 hectares, with an area of 29 000 sq. m.), GMP, ISO
- Capability of implementing new global pharmaceutical technologies on a full cycle
- Three separate sites for different types of pharmaceutical production
- A full line of state-of-the-art laboratory equipment providing quality control of any complexity
Manufacturing facilities
- Solid dosage forms - up to 4 billions of tablets per year
- Filling into syringes – up to 42 millions of syringes per year
- Filling into vials – up to 35 millions of vials per year
- Lyophilic products in vials – up to 1.8 millions of vials per year
